Mansi A. Saksena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mansi A. Saksena has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Barbara L. Smith
1 shared publication- Barbara L. Smith
Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA
1 shared publication D. Gervais
Massachussetts General Hospital
1 shared publication- Debra A. Gervais
Massachusetts General Hospital
1 shared publication - Elena F. Brachtel
Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
1 shared publication Elizabeth A. Rafferty
1 shared publication
Latest Publications
- 30 August 2016
- Published by Cambridge University Press (CUP)
- p. 203-213
Management of small renal masses
- 30 August 2016
- Published by Cambridge University Press (CUP)
- p. 203-213
Management of small renal masses
- 1 February 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1058) , 20150581
Intraoperative micro-computed tomography (micro-CT): a novel method for determination of primary tumour dimensions in breast cancer specimens
Objectives:Micro-CT is a promising modality to determine breast tumour size in three dimensions in intact lumpectomy specimens. We compared the accuracy of tumour size measurements using specimen micro-CT with measurements using multimodality pre-operative imaging.Methods:A tabletop micro-CT was used to image breast lumpectomy specimens. The largest tumour dimension on three-dimensional reconstructed micro-CT images of the specimen was compared with the measurements determined by pre-operative mammography, ultrasound and MRI. The largest dimension of pathologic invasive cancer size was used as the gold standard reference to assess the accuracy of imaging assessments.Results:50 invasive breast cancer specimens in 50 patients had micro-CT imaging. 42 were invasive ductal carcinoma, 6 were invasive lobular carcinoma and 2 were other invasive cancer. Median patient age was 63 years (range 33–82 years). When compared with the largest pathologic tumour dimension, micro-CT measurements had the best correlation c...
- 1 February 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1058) , 20150581
Intraoperative micro-computed tomography (micro-CT): a novel method for determination of primary tumour dimensions in breast cancer specimens
Objectives:Micro-CT is a promising modality to determine breast tumour size in three dimensions in intact lumpectomy specimens. We compared the accuracy of tumour size measurements using specimen micro-CT with measurements using multimodality pre-operative imaging.Methods:A tabletop micro-CT was used to image breast lumpectomy specimens. The largest tumour dimension on three-dimensional reconstructed micro-CT images of the specimen was compared with the measurements determined by pre-operative mammography, ultrasound and MRI. The largest dimension of pathologic invasive cancer size was used as the gold standard reference to assess the accuracy of imaging assessments.Results:50 invasive breast cancer specimens in 50 patients had micro-CT imaging. 42 were invasive ductal carcinoma, 6 were invasive lobular carcinoma and 2 were other invasive cancer. Median patient age was 63 years (range 33–82 years). When compared with the largest pathologic tumour dimension, micro-CT measurements had the best correlation c...
- 1 November 2014
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 34 (7) , 1807-1816
To Do or Not to Do: Axillary Nodal Evaluation after ACOSOG Z0011 Trial
The results of the Z0011 trial are practice-changing, and as they are integrated into the surgical algorithms for breast cancer management, breast imagers will need to redefine their role in the preoperative assessment of the axilla and work collaboratively with surgeons, allowing the most appropriate treatment for each patient. Methods of axillary evaluation in invasive breast cancer continue to evolve. The recent American College of Surgeons Oncology Group Z0011 Trial is a prospective, randomized, multicenter trial that compared the survival and locoregional recurrence rates after complete axillary lymph node dissection (ALND) versus sentinel node biopsy (SNB) alone in women with a positive sentinel node in an effort to avoid the complications associated with ALND. As the results of this trial are implemented clinically, affecting surgical management of axillary metastatic disease, radiologists may need to redefine their role in the preoperative assessment of the axilla. Before the Z0011 trial, breast imagers worked to identify axillary metastases preoperatively, allowing appropriate patients to proceed directly to ALND and avoiding the need for SNB. However, the Z0011 trial concluded that ALND may not be necessary in women with metastatic axillary disease who meet the trial criteria. In the Z0011 trial, after 6 years of median...
- 1 November 2014
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 34 (7) , 1807-1816
To Do or Not to Do: Axillary Nodal Evaluation after ACOSOG Z0011 Trial
The results of the Z0011 trial are practice-changing, and as they are integrated into the surgical algorithms for breast cancer management, breast imagers will need to redefine their role in the preoperative assessment of the axilla and work collaboratively with surgeons, allowing the most appropriate treatment for each patient. Methods of axillary evaluation in invasive breast cancer continue to evolve. The recent American College of Surgeons Oncology Group Z0011 Trial is a prospective, randomized, multicenter trial that compared the survival and locoregional recurrence rates after complete axillary lymph node dissection (ALND) versus sentinel node biopsy (SNB) alone in women with a positive sentinel node in an effort to avoid the complications associated with ALND. As the results of this trial are implemented clinically, affecting surgical management of axillary metastatic disease, radiologists may need to redefine their role in the preoperative assessment of the axilla. Before the Z0011 trial, breast imagers worked to identify axillary metastases preoperatively, allowing appropriate patients to proceed directly to ALND and avoiding the need for SNB. However, the Z0011 trial concluded that ALND may not be necessary in women with metastatic axillary disease who meet the trial criteria. In the Z0011 trial, after 6 years of median...
- 17 December 2008
- Published by Springer Nature in Abdominal Radiology
- Vol. 34 (5) , 582-587
Percutaneous renal tumor ablation
Recent increase in utilization of cross-sectional imaging has resulted in increased detection of early renal cancer. Percutaneous ablation is a relatively new technique for the treatment of renal cancer. This article provides an overview of clinical indications, technique, and results of percutaneous ablation of renal cancer.
- 17 December 2008
- Published by Springer Nature in Abdominal Radiology
- Vol. 34 (5) , 582-587
Percutaneous renal tumor ablation
Recent increase in utilization of cross-sectional imaging has resulted in increased detection of early renal cancer. Percutaneous ablation is a relatively new technique for the treatment of renal cancer. This article provides an overview of clinical indications, technique, and results of percutaneous ablation of renal cancer.
- 22 November 2008
- Published by Springer Nature
- p. 337-345
Cross-Sectional Imaging in Penis Cancer